{"disease":{"id":"depression","name":"depression"},"drugs":{"marketed":[{"drug_id":"aripiprazole","indication_name":"Depression Treatment Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abilify","generic_name":"aripiprazole","company_name":"Generic (originally Otsuka/BMS)","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A, 5-hydroxytryptamine receptor 6","drug_class":"Third-generation antipsychotic (D2 partial agonist)","quality_score":63,"revenue":"3000","mechanism":"Third-generation antipsychotic that acts as a partial agonist at D2 and 5-HT1A receptors, stabilizing dopamine activity rather than simply blocking it."},{"drug_id":"fluoxetine","indication_name":"Bipolar affective disorder, current episode depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prozac","generic_name":"fluoxetine","company_name":"Eli Lilly and Company","drug_phase":"marketed","molecular_target":"Serotonin reuptake transporter","drug_class":"Selective Serotonin Reuptake Inhibitor (SSRI)","quality_score":81,"revenue":"1000.0","mechanism":"Fluoxetine inhibits CNS neuronal uptake of serotonin, though exact mechanism unknown."},{"drug_id":"nalmefene","indication_name":"Opiate-Induced Respiratory Depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Revex","generic_name":"NALMEFENE","company_name":"Hikma","drug_phase":"marketed","molecular_target":"Kappa-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":55,"revenue":"400","mechanism":""},{"drug_id":"olanzapine","indication_name":"Bipolar affective disorder, current episode depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zyprexa","generic_name":"olanzapine","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"Atypical Antipsychotic [EPC]","quality_score":38,"revenue":"300","mechanism":null},{"drug_id":"olanzapine","indication_name":"Depression Treatment Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zyprexa","generic_name":"olanzapine","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"Atypical Antipsychotic [EPC]","quality_score":38,"revenue":"300","mechanism":null},{"drug_id":"zuranolone","indication_name":"Postpartum Depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zurzuvae","generic_name":"ZURANOLONE","company_name":"Biogen","drug_phase":"marketed","molecular_target":"GABA A receptor alpha-4/beta-3/delta","drug_class":"Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]","quality_score":67,"revenue":"100","mechanism":"Zurzuvae works by binding to the GABA A receptor, enhancing the inhibitory effects of GABA to calm overactive neurons."},{"drug_id":"zuranolone","indication_name":"Postpartum depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zurzuvae","generic_name":"ZURANOLONE","company_name":"Biogen","drug_phase":"marketed","molecular_target":"GABA A receptor alpha-4/beta-3/delta","drug_class":"Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC]","quality_score":67,"revenue":"100","mechanism":"Zurzuvae works by binding to the GABA A receptor, enhancing the inhibitory effects of GABA to calm overactive neurons."},{"drug_id":"amitriptyline-hydrochloride","indication_name":"Symptoms of depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"AMITRIPTYLINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":25,"revenue":null,"mechanism":null},{"drug_id":"nortriptyline-hcl","indication_name":"Depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"nortriptyline HCl","company_name":"Zalicus","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":25,"revenue":null,"mechanism":null},{"drug_id":"nortriptyline-hcl","indication_name":"Endogenous Depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"nortriptyline HCl","company_name":"Zalicus","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":25,"revenue":null,"mechanism":null},{"drug_id":"abilify","indication_name":"Depression Treatment Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Abilify","company_name":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A, 5-hydroxytryptamine receptor 6","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"quetiapine","indication_name":"Bipolar affective disorder, current episode depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Seroquel","generic_name":"quetiapine","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"","quality_score":23,"revenue":null,"mechanism":null},{"drug_id":"quetiapine","indication_name":"Depression Treatment Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Seroquel","generic_name":"quetiapine","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"","quality_score":23,"revenue":null,"mechanism":null},{"drug_id":"naloxone","indication_name":"Opiate-Induced Respiratory Depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Narcan","generic_name":"NALOXONE","company_name":"Adapt","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"zulresso","indication_name":"Postpartum depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ZULRESSO®","company_name":"Supernus Pharmaceuticals, Inc.","drug_phase":"marketed","molecular_target":"GABA-A receptor alpha-1/beta-2/gamma-2","drug_class":"Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator","quality_score":21,"revenue":null,"mechanism":""},{"drug_id":"doxapram","indication_name":"Post-Anesthesia Respiratory Depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dopram","generic_name":"DOXAPRAM","company_name":"Hikma","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Respiratory Stimulant","quality_score":48,"revenue":null,"mechanism":""},{"drug_id":"prozac","indication_name":"Bipolar affective disorder, current episode depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Prozac","company_name":"RenJi Hospital","drug_phase":"marketed","molecular_target":"Equilibrative nucleoside transporter 4, 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2A","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"lurasidone","indication_name":"Bipolar affective disorder, current episode depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Latuda","generic_name":"LURASIDONE","company_name":"Sunovion Pharms Inc","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2A","drug_class":"Atypical Antipsychotic","quality_score":80,"revenue":null,"mechanism":"Latuda works by blocking the action of serotonin at the 5-hydroxytryptamine receptor 2A, which helps to regulate mood and reduce symptoms of psychosis."},{"drug_id":"doxepin","indication_name":"Bipolar affective disorder, current episode depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zonalon","generic_name":"DOXEPIN","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Tricyclic Antidepressant","quality_score":80,"revenue":null,"mechanism":"Zonalon works by blocking histamine H1 receptors in the brain, which helps to reduce anxiety and itching, and improve mood."},{"drug_id":"doxepin","indication_name":"Severe major depression with psychotic features","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zonalon","generic_name":"DOXEPIN","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Tricyclic Antidepressant","quality_score":80,"revenue":null,"mechanism":"Zonalon works by blocking histamine H1 receptors in the brain, which helps to reduce anxiety and itching, and improve mood."},{"drug_id":"brexanolone","indication_name":"Postpartum depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zulresso","generic_name":"BREXANOLONE","company_name":"Sage Therap","drug_phase":"marketed","molecular_target":"GABA-A receptor alpha-1/beta-2/gamma-2","drug_class":"Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"seroquel","indication_name":"Bipolar affective disorder, current episode depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Seroquel","company_name":"University of Pittsburgh","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"seroquel","indication_name":"Depression Treatment Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Seroquel","company_name":"University of Pittsburgh","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"quetiapin","indication_name":"Bipolar affective disorder, current episode depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Quetiapin","company_name":"Sykehuset Innlandet HF","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"quetiapin","indication_name":"Depression Treatment Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Quetiapin","company_name":"Sykehuset Innlandet HF","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"zyprexa","indication_name":"Bipolar affective disorder, current episode depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Zyprexa","company_name":"Washington University School of Medicine","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"zyprexa","indication_name":"Depression Treatment Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Zyprexa","company_name":"Washington University School of Medicine","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"bat","indication_name":"Treatment of treatment-resistant depression in adults","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bat","generic_name":"bat","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Unknown","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"nardil","indication_name":"Atypical Depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nardil","generic_name":"Phenelzine Sulfate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Amine oxidase [flavin-containing] B","drug_class":"Monoamine Oxidase Inhibitor","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"nardil","indication_name":"Mixed Anxiety and Depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nardil","generic_name":"Phenelzine Sulfate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Amine oxidase [flavin-containing] B","drug_class":"Monoamine Oxidase Inhibitor","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"nardil","indication_name":"Severe Depression with Endogenous Features","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nardil","generic_name":"Phenelzine Sulfate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Amine oxidase [flavin-containing] B","drug_class":"Monoamine Oxidase Inhibitor","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"imipramine","indication_name":"Depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tofranil","generic_name":"IMIPRAMINE","company_name":"","drug_phase":"marketed","molecular_target":"Sodium-dependent serotonin transporter","drug_class":"Tricyclic Antidepressant","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"lurasidone","indication_name":"Bipolar Depression (Adjunctive Therapy)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Latuda","generic_name":"LURASIDONE","company_name":"Sunovion Pharms Inc","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2A","drug_class":"Atypical Antipsychotic","quality_score":80,"revenue":null,"mechanism":"Latuda works by blocking the action of serotonin at the 5-hydroxytryptamine receptor 2A, which helps to regulate mood and reduce symptoms of psychosis."},{"drug_id":"lurasidone","indication_name":"Bipolar Depression (Monotherapy)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Latuda","generic_name":"LURASIDONE","company_name":"Sunovion Pharms Inc","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2A","drug_class":"Atypical Antipsychotic","quality_score":80,"revenue":null,"mechanism":"Latuda works by blocking the action of serotonin at the 5-hydroxytryptamine receptor 2A, which helps to regulate mood and reduce symptoms of psychosis."}],"pipeline":[{"drug_id":"scopolamine","indication_name":"Bipolar depression","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SCOPOLAMINE","company_name":"","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptors","drug_class":"Anticholinergic [EPC]","quality_score":55,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":34,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT04946955","title":"Adaptation of a French E-health Tool for Suicide Prevention in Young Populations","phase":"NA","overall_status":"UNKNOWN","enrollment_count":12000000,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05137977","title":"Is Invasive ICU-treatment Associated With Mental Illness?","phase":"","overall_status":"COMPLETED","enrollment_count":1048576,"lead_sponsor_name":"Uppsala University","has_results":false},{"nct_id":"NCT05813652","title":"Relative Impacts on Preventative Primary Care--a Longitudinal Evaluation of COVID-19:Phase 1","phase":"","overall_status":"COMPLETED","enrollment_count":919928,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT04446039","title":"Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea","phase":"","overall_status":"COMPLETED","enrollment_count":370212,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03987633","title":"EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality","phase":"","overall_status":"RECRUITING","enrollment_count":200000,"lead_sponsor_name":"Future Genetics Limited","has_results":false},{"nct_id":"NCT03944447","title":"Outcomes Mandate National Integration With Cannabis as Medicine","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":200000,"lead_sponsor_name":"OMNI Medical Services, LLC","has_results":false},{"nct_id":"NCT02681848","title":"What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?","phase":"","overall_status":"UNKNOWN","enrollment_count":180000,"lead_sponsor_name":"University of Bristol","has_results":false},{"nct_id":"NCT06115200","title":"Norwegian Adult Mental Health Registry","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":150000,"lead_sponsor_name":"Helse Stavanger HF","has_results":false},{"nct_id":"NCT03285230","title":"The French E3N Prospective Cohort Study","phase":"","overall_status":"UNKNOWN","enrollment_count":100000,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT07453420","title":"Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections: Translating Epidemiology to Deep-phenotyping.","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Shalvata Mental Health Center","has_results":false},{"nct_id":"NCT03565562","title":"Preventing Psychological Distress and Suicidal Behaviours: a Web-based and Mobile Suicide Prevention Intervention in the General Population","phase":"NA","overall_status":"COMPLETED","enrollment_count":100000,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT06903897","title":"Social Needs Screening and Chronic Diseases Study (WE CARE)","phase":"NA","overall_status":"RECRUITING","enrollment_count":68000,"lead_sponsor_name":"University of Massachusetts, Worcester","has_results":false},{"nct_id":"NCT06301087","title":"Early Detection Neurodevelopmental Disorders of Children and Prevention of Postnatal Depression by Mobile Health App","phase":"","overall_status":"COMPLETED","enrollment_count":55618,"lead_sponsor_name":"Weprom","has_results":false},{"nct_id":"NCT01088542","title":"The Community Youth Development Study: A Test of Communities That Care","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":52323,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT03633825","title":"Brief Online Help-seeking Barrier Reduction Intervention","phase":"NA","overall_status":"COMPLETED","enrollment_count":39450,"lead_sponsor_name":"Harvard University","has_results":true},{"nct_id":"NCT05123794","title":"Shortened Depression Assessment Study","phase":"","overall_status":"COMPLETED","enrollment_count":39000,"lead_sponsor_name":"University of Toronto","has_results":false},{"nct_id":"NCT03987360","title":"Educational and Cultural Engagement and Incidence of Health Adverse Events","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30000,"lead_sponsor_name":"Jewish General Hospital","has_results":false},{"nct_id":"NCT03679221","title":"Motoric Cognitive Risk and Depression","phase":"","overall_status":"UNKNOWN","enrollment_count":30000,"lead_sponsor_name":"Jewish General Hospital","has_results":false},{"nct_id":"NCT03799861","title":"Newborn Heart Rate as a Catalyst for Improved Survival","phase":"","overall_status":"COMPLETED","enrollment_count":24034,"lead_sponsor_name":"American Academy of Pediatrics","has_results":false},{"nct_id":"NCT06818227","title":"MonPsy&Moi: A Digital Platform for Collecting Patient-Reported Experience and Outcome Measures in Psychiatry","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":23660,"lead_sponsor_name":"Assistance Publique Hopitaux De Marseille","has_results":false},{"nct_id":"NCT05110014","title":"Substudy of Protocol NCT03843957 - Effect of mPATH on Screening for Depression, Fall Risk, and Safety","phase":"NA","overall_status":"COMPLETED","enrollment_count":23026,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":true},{"nct_id":"NCT04558437","title":"COVID-Impact \"Psychological IMPACT of Covid-19 on AP-HP Staff\"","phase":"","overall_status":"UNKNOWN","enrollment_count":20000,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05074901","title":"Virtual Agents-based Digital Interventions to Improve Health","phase":"NA","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"University of Bordeaux","has_results":false},{"nct_id":"NCT05455905","title":"Voice Biomarkers Predictive of Depression and Anxiety","phase":"","overall_status":"COMPLETED","enrollment_count":19533,"lead_sponsor_name":"Kintsugi Mindful Wellness, Inc.","has_results":false},{"nct_id":"NCT07224347","title":"Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":19114,"lead_sponsor_name":"Anne Murray","has_results":false},{"nct_id":"NCT03470584","title":"Vegetarian Diet and Chronic Degenerative Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":18064,"lead_sponsor_name":"Dalin Tzu Chi General Hospital","has_results":false},{"nct_id":"NCT00024635","title":"Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers","phase":"","overall_status":"RECRUITING","enrollment_count":16000,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT05963516","title":"Bedside Improvement of Resuscitation Through mHealth Feedback (BIRTH Study)","phase":"NA","overall_status":"COMPLETED","enrollment_count":14130,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT06692842","title":"Interactive Technological Intervention to Improve Mental Health Symptoms in Primary Health Care","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":12400,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT03994809","title":"International Study of Biofield Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":12000,"lead_sponsor_name":"MOA Health Science Foundation","has_results":false},{"nct_id":"NCT04792086","title":"Disease Containment Measures Among Older Adults During the Covid-19 Pandemia","phase":"","overall_status":"UNKNOWN","enrollment_count":12000,"lead_sponsor_name":"Norwegian Centre for Ageing and Health","has_results":false},{"nct_id":"NCT04786561","title":"Depression, Anxiety and Social Relationships as Risk Factors for Dementia","phase":"","overall_status":"COMPLETED","enrollment_count":11000,"lead_sponsor_name":"Norwegian Centre for Ageing and Health","has_results":false},{"nct_id":"NCT03217058","title":"Computerized Substance Use and Depression Screening and Behavioral Treatment in HIV Primary Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":10821,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT05764213","title":"Improving Maternal Mental Health & SUD Screening and Treatment","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10470,"lead_sponsor_name":"Medical University of South Carolina","has_results":false},{"nct_id":"NCT04365881","title":"Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology","phase":"","overall_status":"COMPLETED","enrollment_count":10084,"lead_sponsor_name":"Modum Bad","has_results":false},{"nct_id":"NCT04356365","title":"The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's)","phase":"","overall_status":"COMPLETED","enrollment_count":10084,"lead_sponsor_name":"University of Oslo","has_results":false},{"nct_id":"NCT03672448","title":"The China Longitudinal Aging Study of Cognitive Impairment","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Shanghai Mental Health Center","has_results":false},{"nct_id":"NCT04905524","title":"Activity Changes in Irritable Bowel Syndrome (IBS), Anxiety, and Depression Following the Use of Viome Precision Nutrition Program (VPNP)","phase":"NA","overall_status":"COMPLETED","enrollment_count":10000,"lead_sponsor_name":"Viome","has_results":false},{"nct_id":"NCT04343664","title":"Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Tjhin Wiguna","has_results":false},{"nct_id":"NCT06338215","title":"Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality","phase":"NA","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Clinica Universidad de Navarra, Universidad de Navarra","has_results":false},{"nct_id":"NCT04256720","title":"The Multi-Ethnic Lifestyle Study","phase":"","overall_status":"UNKNOWN","enrollment_count":9500,"lead_sponsor_name":"University of Leicester","has_results":false},{"nct_id":"NCT06351800","title":"The PredictPlusPrevent Study","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":9000,"lead_sponsor_name":"The Mediterranean Institute for the Advance of Biotechnology and Health Research","has_results":false},{"nct_id":"NCT07532122","title":"Postoperative Anxiety and Depression Among Chinese Elderly Patients","phase":"","overall_status":"COMPLETED","enrollment_count":8590,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT06495840","title":"Postoperative Anxiety and Depression Among Older Chinese Patients","phase":"","overall_status":"COMPLETED","enrollment_count":8590,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT04498442","title":"A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls","phase":"NA","overall_status":"COMPLETED","enrollment_count":8519,"lead_sponsor_name":"Beth Israel Deaconess Medical Center","has_results":false},{"nct_id":"NCT04377412","title":"Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic","phase":"","overall_status":"UNKNOWN","enrollment_count":8500,"lead_sponsor_name":"Żelazna Medical Centre, LLC","has_results":false},{"nct_id":"NCT06122688","title":"By Youth, For Youth: Digital Supported Peer Navigation for Addressing Child Mental Health Care","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":8360,"lead_sponsor_name":"University of California, Riverside","has_results":false},{"nct_id":"NCT03632122","title":"Subgroups of Older Adults With Back Pain and Multiple Chronic Conditions","phase":"","overall_status":"COMPLETED","enrollment_count":8344,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT04595123","title":"Impact of COVID-19 Pandemic in Perinatal Mental Health (RISEUP-PPD-COVID-19)","phase":"","overall_status":"COMPLETED","enrollment_count":7642,"lead_sponsor_name":"University of Minho","has_results":false},{"nct_id":"NCT06856668","title":"A Megastudy of Single-Session Interventions for Depression","phase":"NA","overall_status":"COMPLETED","enrollment_count":7505,"lead_sponsor_name":"Northwestern University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}